25 September 2023: Aker BioMarine, together with its South Korean partner,
successfully reintroduced Superba sales in South Korea through a TV home
shopping launch yesterday. Results came in at the TV channel's target, with good
levels of interest and momentum to enable the local partner to continue to build
the launch marketing campaign as planned. The company will continue to work
closely with its local partner to gradually rebuild the South Korean market in
the coming weeks and months ahead.

Further information will be provided in company's Q3 2023 report released on 1
November 07:00.   

For further information, please contact 
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820 
Email:  Christopher.vinter@akerbiomarine.com  

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.